Q and A Session with Drs. Ben Solomon and Ross Camidge on ALK Inhibition for Advanced NSCLC (audio)
- Author
- cancerGRACE - H. Jack West, MD
- Published
- Mon 21 Nov 2011
- Episode Link
- http://cancergrace.libsyn.com/q-a-session-with-drs-ben-solomon-and-ross-camidge-on-alk-inhibition-for-advanced-nsclc-audio-
Drs. Ben Solomon (Peter MacCallum Cancer Center in Melbourne) and Ross Camidge (Univ. of Colorado) answer Qs on ALK rearrangements and crizotinib (XALKORI) for advanced non-small cell lung cancer (NSCLC).
